Aviado · Research
Longevity Daily
Thursday, April 30, 2026
Listen
Today's Brief
Today's lead story challenges one of biohacking's most popular bets: rapamycin may blunt the very exercise benefits that underpin longevity, a must-read finding for the thousands now taking it off-label. On the cognitive front, new data shows that even modest ultra-processed food intake raises dementia risk — and that cutting back in midlife still meaningfully reduces it. A landmark human clinical trial confirms the Fasting Mimicking Diet activates autophagy in humans for the first time, while Aviado's new MTHFR explainer reveals why your folic acid regimen may be working against you.
10 stories2 peer-reviewed1 trials1 Aviado original
Cognitive Health & Neuroprotection
Major Medical Group Issues First Comprehensive Definition of Brain Health Across the Lifespan
The American Heart Association has released a new scientific statement formally defining brain health across all life stages — and the modifiable factors list is actionable: mental health, sleep quality, social connection, and limiting environmental exposures all make the cut. The statement explicitly links the AHA's Life's Essential 8 framework (diet, exercise, sleep, blood pressure control) to measurable cognitive aging outcomes. For anyone optimizing for long-term brain function, this is a useful, evidence-grounded roadmap from one of medicine's most credible institutions.
Read more →Even Small Amounts of Ultra-Processed Food Raise Dementia Risk — and Cutting Back in Midlife Still Helps
A new study finds that adults in their 50s and 60s who reduced ultraprocessed food intake over a decade had an 11% lower risk of Alzheimer's disease and dementia compared to those whose diets didn't change. The key message: there's no safe floor for UPF consumption, but it's also not too late to act — midlife dietary changes register as meaningful protection. If cognitive longevity is a priority, what you eat in your 50s may be one of your highest-leverage interventions.
Read more →Supplements & Compounds
Fish Oil's EPA May Interfere With Brain Repair After Repeated Head Injuries
A new study from the Medical University of South Carolina finds that EPA — one of the key omega-3 fatty acids in fish oil — may slow the brain's natural repair processes after repeated mild head injuries, complicating the conventional wisdom that fish oil is universally brain-protective. This is not a reason to ditch fish oil if you have no history of head trauma, but it's a significant caveat for athletes in contact sports or anyone with a concussion history. The study underscores why blanket supplement recommendations are increasingly being replaced by individualized guidance.
Read more →Your MTHFR Genotype Determines Whether Folic Acid Helps or Harms You
The same folic acid dose that dramatically cuts heart disease risk in one person may do nothing — or actively accumulate as potentially harmful unmetabolized folic acid (UMFA) — in another, depending on your MTHFR gene variant. A 2024 study found people with two slow MTHFR genes (TT type) needed to skip folic acid entirely and switch to methylfolate to get equivalent benefits. Aviado's analysis breaks down exactly which form and dose matches each genotype, and why testing homocysteine and RBC folate at 12 weeks is the only way to confirm your regimen is actually working.
Read the full Aviado analysis →Research & Papers
Rapamycin May Blunt the Longevity Benefits of Exercise, New Study Warns
Rapamycin, the transplant drug taken off-label by thousands of longevity enthusiasts, may have a critical downside: new research suggests it interferes with one of the primary biological mechanisms through which exercise extends lifespan. The drug works by inhibiting mTOR — the same pathway that exercise activates to build muscle and improve mitochondrial function — putting users in a direct physiological conflict between the drug and their workouts. This doesn't mean rapamycin is worthless, but it raises serious questions about timing, dosing, and whether the off-label longevity case holds up when exercise is part of the equation. If you're taking rapamycin, this is the most important piece you'll read this week.
Read more →What Centenarians' Immune Systems Reveal About the Most Overlooked Driver of Aging
A new review of centenarian biology finds that their immune systems age measurably more slowly than those of the general population — pointing to immunosenescence, the gradual decline in immune efficacy with age, as a central driver of degenerative aging rather than a downstream consequence of it. The takeaway isn't that you can directly emulate centenarians, but that preserving immune function into old age may be among the highest-leverage interventions available. The authors argue this area deserves significantly more attention from the longevity research and development community.
Read more →A Supplement Combo Claims Sizable Lifespan Extension in Mice — But the Caveats Are Significant
A company called Seragon funded a study claiming its proprietary supplement combination outperformed rapamycin alone in extending lifespan in aged mice — but the company hasn't fully disclosed all ingredients, and industry-funded mouse longevity studies have a poor track record of replicating in humans. The NIA's rigorous Interventions Testing Program has repeatedly failed to confirm lifespan benefits that initially looked promising in smaller rodent studies. Worth watching, but healthy skepticism is warranted before reading too much into these results.
Read more →Lifestyle & Nutrition
First Human Clinical Trial Confirms the Fasting Mimicking Diet Activates Autophagy
A clinical trial published in GeroScience has — for the first time in humans — demonstrated that the Fasting Mimicking Diet (FMD), a five-day low-calorie protocol, activates autophagy, the cellular self-cleaning process long associated with longevity in animal models. Decades of preclinical data suggested this was possible, but human evidence has lagged until now. One important caveat: the trial was funded by L-Nutra, the company that manufactures the ProLon FMD kit, so independent replication will be important.
Read more →Industry & Policy
Infinite Epigenetics Acquires Tally Health in Largest Epigenetic Testing Deal to Date
David Sinclair's Infinite Epigenetics has acquired Tally Health, consolidating what the company claims is the world's largest private adult DNA methylation dataset with a consumer-facing longevity platform. The deal signals a significant maturation — and consolidation — of the biological age testing market, and could accelerate personalized supplement recommendations driven by epigenetic data at scale. Watch this space: datasets of this size could yield genuinely useful insights, though the commercial incentives to market aggressively around them are equally significant.
Read more →The Dietary Supplement Listing Act of 2026 Would Require Every Supplement to Register With the FDA
Proposed legislation would require every dietary supplement sold in the US to be formally listed with the FDA — a significant regulatory shift for an industry that has historically operated with minimal pre-market oversight. The compliance burden would fall on manufacturers, packers, and distributors. For consumers, if passed, this could eventually mean meaningfully greater accountability and transparency about what's actually in the products on store shelves.
Read more →